PROTIOMIX_LIMITED_30_Jun_2023_companies_house_set_of_accounts.html

PROTIOMIX_LIMITED_30_Jun_2023_companies_house_set_of_accounts.html


25 June 2022 v2024.8.1 limited_company_frs_102_section_1a_v1_1_1 companies_houseSoftwarefalsetruetruetrueNo description of principal activity0falsetruexbrli:purexbrli:sharesiso4217:GBP141955152022-06-252023-06-30141955152023-06-3014195515core:WithinOneYear2023-06-3014195515core:ShareCapital2023-06-3014195515core:RetainedEarningsAccumulatedLosses2023-06-3014195515bus:Director12022-06-252023-06-3014195515bus:RegisteredOffice2022-06-252023-06-301419551512022-06-252023-06-3014195515countries:EnglandWales2022-06-252023-06-3014195515bus:AuditExempt-NoAccountantsReport2022-06-252023-06-3014195515bus:PrivateLimitedCompanyLtd2022-06-252023-06-3014195515bus:SmallEntities2022-06-252023-06-3014195515bus:FullAccounts2022-06-252023-06-30
Company registration number:
14195515
Protiomix Limited
Unaudited Filleted Financial Statements for the period ended
30 June 2023
Protiomix Limited
Statement of Financial Position
30 June 2023
30 Jun 2023
Note£
Current assets  
Debtors 5
31,950
 
Cash at bank and in hand
27,088
 
59,038
 
Creditors: amounts falling due within one year 6
(15,075
)
Net current assets
43,963
 
Total assets less current liabilities 43,963  
Capital and reserves  
Called up share capital
64,004
 
Profit and loss account
(20,041
)
Shareholders funds
43,963
 
For the period ending
30 June 2023
, the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
  • The members have not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;
  • The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These
financial statements
have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies’ regime.
In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered.
These
financial statements
were approved by the board of directors and authorised for issue on
25 March 2024
, and are signed on behalf of the board by:
Dr S Jaffe
Director
Company registration number:
14195515
Protiomix Limited
Notes to the Financial Statements
Period ended
30 June 2023

1 General information

The company is a private company limited by shares and is registered in England and Wales. The address of the registered office is
28 Chesterton Road
,
Cambridge
,
CB4 3AZ
, England.

2 Statement of compliance

These
financial statements
have been prepared in compliance with FRS 102 Section 1A, 'The Financial Reporting Standard applicable to the UK and Republic of Ireland'.

3 Accounting policies

Basis of preparation

The
financial statements
have been prepared on the historical cost basis, as modified by the revaluation of certain assets.
The
financial statements
are prepared in sterling, which is the functional currency of the company.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer, usually on despatch of the goods; the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

4 Average number of employees

The average number of persons employed by the company during the period was Nil.

5 Debtors

30 Jun 2023
£
Other debtors
31,950
 

6 Creditors: amounts falling due within one year

30 Jun 2023
£
Other creditors
15,075